Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ron DePinho: CRISPR Progress in Cellular Immunotherapy
Ron DePinho and Heidi Ledford
Mar 24, 2026, 17:12

Ron DePinho: CRISPR Progress in Cellular Immunotherapy

Ron DePinho, Professor and Past President of MD Anderson Cancer Center, shared a post on LinkedIn about a recent article by Heidi Ledford, adding:

”CRISPR progress in cellular immunotherapy …

Researchers used a combination of engineered viruses and virus-like particles to target T cells. The particles carried RNA and protein machinery needed for CRISPR–Cas9 gene editing, and the viruses contained the DNA encoding the CAR protein. T cells had to receive both payloads to become a CAR T cell.

In mice with leukaemia and multiple myeloma, tumors were completely wiped out in the treated mice, and more than half of the treated group with sarcomas entered full remission. A biotechnology company, Azalea Therapeutics is now testing the approach in monkeys and hopes to have clinical trials in people by the end of next year. While encouraging, it remains to be seen how long the effects of the treatment last, or whether CRISPR–Cas9 might be introducing any unwanted changes to the genome.”

Title: CRISPR makes enhanced cancer-fighting immune cells inside mice

Author: Heidi Ledford

Read the Full Article on Nature

Ron DePinho: CRISPR Progress in Cellular Immunotherapy

Stay updated on all scientific advances with Hemostasis Today.

CAR protein CRISPR CRISPR–Cas9 gene DNA Health Hematology Hemostasis Hemostasis News Hemostasis Today Leukaemia Medicine Ron DePinho T Cells
NewsFeed